What adjuvant treatment (if any) would you recommend for a post-menopausal patient with a borderline T1b (0.5 cm) grade 2 ER+/PR+/HER2 negative invasive lobular breast CA after bilateral mastectomies?
Answer from: Medical Oncologist at Academic Institution
My evaluation and plan for any patient with breast cancer seen in the Stage 0-3 setting tends to follow a similar pattern. The risks include:
Distant recurrence
Local recurrence
New breast primaries
Side effects of therapy
The systemic therapy options for lowering these 3 categories of risk in ...
Comments
Medical Oncologist at St Lukes Cancer Care Assocs Certainly no chemo.
To discuss ET or not. Small g...
Medical Oncologist A very organized approach to assessing risk/benefi...
Medical Oncologist at Warren Alpert Medical School of Brown University Would offer a trial of adjuvant endocrine therapy ...
Certainly no chemo. To discuss ET or not. Small g...
A very organized approach to assessing risk/benefi...
Would offer a trial of adjuvant endocrine therapy ...